Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

U.S. Genomics Announces Recipient of Outstanding Investigator in Single Molecule Biology Award

Published: Tuesday, February 21, 2006
Last Updated: Tuesday, February 21, 2006
Bookmark and Share
Dr. James A. Spudich will be presented the award at the 50th Annual Meeting of the Biophysical Society.

U.S. Genomics has announced that Dr. James A. Spudich of Stanford University is the recipient of the Company's first annual award for Outstanding Investigator Single Molecule Biology Award.

The award will be presented at the 50th Annual Meeting of the Biophysical Society in Salt Lake City, Utah.

The Biophysical Society Awards Program honors its members by recognizing excellence in biophysics and promoting interaction among life scientists throughout the world.

"Biology happens at the molecular level. Dr. Spudich's research achievements with myosin demonstrate the importance of working at the level of single molecules to discover the basis of fundamental cellular processes," said John J. Canepa, CEO of U.S. Genomics.

"As the pioneer of single molecule biology tools, U.S. Genomics is proud to sponsor an award that recognizes and promotes outstanding contributions in this field. The Biophysical Society Annual Meeting offers a premier venue in which to acknowledge Dr. Spudich's great achievements."

"The Biophysical Society is pleased to recognize Dr. Spudich's longstanding efforts to further the study of the molecular basis of cell motility through single molecule approaches," said Steven M. Block, President of the Biophysical Society.

"U.S. Genomics' award will encourage future exploration and acknowledge excellence in this advanced area of biophysics research."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

U.S. Genomics Announces New Chief Executive Officer
John J. Canepa has been promoted to President, CEO and member of the Board of Directors.
Friday, December 16, 2005
NSF Awards U.S. Genomics a $500K Phase II-B SBIR Grant
The $500,000 grant is earmarked for development of a commercial platform that uses the Company's rapid DNA analysis and genomic mapping technologies.
Friday, October 07, 2005
U.S. Genomics Expands its Efforts With New VP
U.S. Genomics Names Duncan Whitney as Vice President of Research and Development.
Friday, September 30, 2005
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!